Extensive clinical trials focusing on metastatic castration-resistant prostate cancer, evaluating novel therapeutic combinations and treatment approaches.

Advanced treatment combinations
Hormone therapy optimization
High-risk localized disease management

Studies examine innovative drug combinations including enzalutamide and emerging therapeutic agents.

02 Gastrointestinal Oncology

Research focusing on advanced treatments for colorectal cancer and pancreatic adenocarcinoma, exploring targeted therapies and chemotherapy combinations.

Targeted molecular therapies
First-line treatment optimization
Circulating tumor DNA analysis

Innovative approaches in treatment selection and monitoring for better patient outcomes.

03 Breast Cancer Innovations

Comprehensive studies on hormone-sensitive breast cancer, investigating treatment duration optimization and novel therapeutic combinations.

Hormone therapy duration
Targeted treatments
Personalized medicine approaches

Focus on improving outcomes for specific patient subgroups through tailored therapeutic strategies.

Back to France All countries

Clinical trials in Saint-Gregoire – page 4

54 trials in Saint-Gregoire

Prostate cancer

Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

Hormone-refractory prostate cancer

Study of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer

Squamous cell carcinoma of head and neck

Study Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma

Breast cancer female

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Prostate cancer

A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

Colorectal cancer+1

Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

Hormone receptor positive HER2 negative breast cancer

Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Lung neoplasm malignant

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Squamous cell carcinoma of head and neck

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Anti-neutrophil cytoplasmic antibody positive vasculitis+1

Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

Filter the trials

Other cities in France

Clinical research in Saint-Gregoire

Prefer not to search? Our Concierge searches the trials for you.